Oct 19, 2024, 16:54
Mark Lythgoe: Big rise in number of UK cancers – post-pandemic effect or better early detection
Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared on X:
“Big rise in number of UK cancers especially prostate cancer – post-pandemic effect or better early detection?
Certainly more resources needed.”
Mark Lythgoe is a Clinical Research Fellow in Medical Oncology at Imperial College London and a Specialist Registrar/Academic Clinical Fellow at Imperial College Healthcare NHS Trust. His research focuses on oncology therapy and drug development, in collaboration with global pharmaceutical companies to develop new cancer therapies.
His other research interests include early-phase oncology studies, biomarker development, intra-tumoral microbiome analysis, Mendelian randomization, and meta-data analysis.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48
Nov 13, 2024, 23:46